Citation Impact

Citing Papers

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop
1999 Standout
Recent insights into antiphospholipid antibody-mediated thrombosis
1999
Methods for evaluation of platelet function
2009 StandoutNobel
Portal Vein Thrombosis After Elective Splenectomy
1993
Which are the Best Biological Markers of the Antiphospholipid Syndrome?
2000
Immunology of the antiphospholipid antibody syndrome
1996
Nutraceuticals: Facts and fiction
2007 Standout
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Hepatobiliary implications and complications in protoporphyria, a 20-year study
1989
The molecular basis of blood coagulation
1988 Standout
Porphyrias
2010 Standout
Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria
2004 Standout
Vascular disorders of the liver # †
2008 Standout
Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy
2001
Clinical characteristics of antiphospholipid antibody syndrome in children
1996
The effect of gamma irradiation on the quality of apheresis platelets during storage for 7 days
2008 StandoutNobel
Antithrombotic Therapy for VTE Disease
2012 Standout
The Antiphospholipid Syndrome
2002 Standout
Cerebral Sinovenous Thrombosis in Children
2001 Standout
Reporting standards in venous disease: An update
1995 Standout
Patients with anticardiolipin antibodies with and without antiphospholipid syndrome: their clinical features and β2‐glycoprotein‐l plasma levels
1992
Binding specificity of lupus anticoagulants and anticardiolipin antibodies
1988
Laboratory diagnosis of the antiphospholipid syndrome
2002
Blood exchange and transfusion therapy for acute cholestasis in protoporphyria
1988
Diagnostic criteria and classification of mastocytosis: a consensus proposal
2001 Standout
Antiphospholipid syndrome and the skin
1997
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
In Vitro Assessment of the Quality of Stored Platelet Concentrates
1994 Standout
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Many faces of lupus anticoagulants
1998
Stimulation of fibrinogen synthesis: a possible functional role of fibrinogen degradation products
1980
STUDIES ON THE PATHOGENESIS OF THROMBOSIS: AN EXPERIMENTAL "HYPERCOAGULABLE" STATE INDUCED BY THE INTRAVENOUS INJECTION OF ELLAGIC ACID.
1964
The Relation Between Response to Hypotonic Stress and the 51Cr Recovery In Vivo of Preserved Platelets
1974
Cutaneous manifestations associated with the presence of the lupus anticoagulant
1986
Liver disease in erythropoietic protoporphyria: insights and implications for management
2007
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Immunology and Clinical Importance of Antiphospholipid Antibodies
1991
Effect of Storage up to 48 Hours on Response to Transfusions of Platelet Rich Plasma
1964
Erythropoietic protoporphyria
1997
Congenital Thrombocytopenia with Giant Platelets: a Defect in the Platelet Membrane
1969
Direct evidence for the contractile capacity of endothelial cells
1981
MEASUREMENT OF PLATELET ADHESIVENESS. A SIMPLE IN VITRO TECHNIQUE DEMONSTRATING AN ABNORMALITY IN VON WILLEBRAND'S DISEASE.
1963 Standout
Polycythemia vera: myths, mechanisms, and management
2002
The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction.
1987 StandoutNobel
Annexins: From Structure to Function
2002 Standout
Interaction of cultured human fibroblasts with fibrin: modification by drugs and aging in vitro.
1973
Platelet Preservation
1969 Standout
THE PHENOMENON OF THE ACUTE PHASE RESPONSE*
1982 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Thrombosis in Patients with the Lupus Anticoagulant
1980
MECHANISM OF ACTION OF THROMBIN ON PLATELETS*
1962
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Platelet Functional Abnormalities: A Report of Two Familial Defects in Interaction Between Collagen and Platelets and ADP Release
1971
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
1990 Standout
A FAMILIAL HEMORRHAGIC TRAIT ASSOCIATED WITH A DEFICIENCY OF A CLOT-PROMOTING FRACTION OF PLASMA 1
1955
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout
Fibroblasts, myofibroblasts, and wound contraction
1994 Standout

Works of Conley Cl being referenced

A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus
1952
Effects of reptilase and thrombin on human blood platelets and observations on the molecular mechanism of clot retraction.
1967
The role of surface and of calcium in the coagulation of a globulin fraction of platelet-deficient plasma.
1951
Clot retraction as a measure of platelet function. II. Clinical disorders associated with qualitative platelet defects (thrombocytopathic purpura).
1953
Studies on afibrinogenemia. II. The defibrinating effect on dog blood of intravenous injection of thromboplastic material.
1951
Recovery from hepatic decompensation in protoporphyria.
1979
Systemic mastocytosis in a patient with polycythemia vera treated with radioactive phosphorus
1977
Thrombosis of the portal vein following splenectomy for myeloid metaplasia.
1981
Polycythemia vera, diagnosis and treatment.
1987
Clot retraction as a measure of platelet function. I. Effects of certain experimental conditions on platelets in vitro.
1953
Rankless by CCL
2026